MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MREO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	10:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	07:38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	05:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05:49	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05:01	GlobeNewswire Inc.	Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/04/03	20:30	GlobeNewswire Inc.	Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/03/28	05:01	GlobeNewswire Inc.	Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/03/05	21:30	GlobeNewswire Inc.	Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/07	06:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/27	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/27	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/24	06:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/08	21:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/08	21:00	GlobeNewswire Inc.	Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2023/12/19	06:16	Edgar (US Regulatory)	Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]	NASDAQ:MREO	Mereo BioPharma Group PLC
2023/12/19	06:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:MREO	Mereo BioPharma Group PLC